Apellis Pharmaceuticals

-$0.39 (-1.16%) Today
$0.00 (0.00%) As of 8:02 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product.

CEO
Cedric Francois
Employees
374
Headquarters
Waltham, Massachusetts
Founded
2009

APLS Key Statistics

Market Cap
2.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
754.70K
High Today
$34.29
Low Today
$33.09
Open Price
$33.83
Volume
564.36K
52 Week High
$73.00
52 Week Low
$27.50

APLS Earnings

-$2.72
-$1.50
-$0.29
$0.93
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure